Finland's pharma exports rise 4% in first part of 2015

28 November 2015
helsinki-big

Among the Finnish chemical industry, the pharmaceutical industry was the exports growth driver sector as shown by the financial review published by the Chemical Industry Federation this month.

Between January and August, medicine exports grew by 4% compared with the same period in the preceding year, according to a web posting by the trade group Pharma Industry Finland (PIF).

The pharmaceutical industry accounts for a larger proportional share due to both its own growth in terms of euro and the decrease in the export of other chemical industry product sectors. In the first part of the year, the pharmaceutical industry exports rose to over 650 million euros ($692 million), representing about 10% of the aggregate chemical industry exports. The annual added value generated by the pharmaceutical industry has grown to 1.3 billion euros, which represents almost 30% of the total valued added of the chemical industry.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical